India's Pharmaceutical Exports

Country Profile

Peru

Peru is a growing market for Indian pharmaceuticals — $110M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 78% of shipments, with vaccines contributing $8.18M. The compound annual growth rate since FY2015 stands at 10.9%.

🇵🇪 $110M · 3.1× growth since FY2015 · 10.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$110M
Exports FY2025–26 DGCIS
3.1×
Growth FY2015→2026
10.9%
CAGR FY2015→2026
78%
Medicines Share
5
Product Categories Supplied
Peru is a growing market for Indian pharmaceuticals — $110M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 78% of shipments, with vaccines contributing $8.18M. The compound annual growth rate since FY2015 stands at 10.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $85.4M (78.0%) Medicine Ingredients $9.41M (8.6%) Vaccines $8.18M (7.5%) Surgical & Hospital Supplies $6.18M (5.6%) Traditional & Herbal $371K (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Peru in the RBI overseas direct investment dataset (2011–2026).